Illumina Price Target Increased to $74.00 by Analysts at Goldman Sachs Group Inc. (ILMN)
Research analysts at Goldman Sachs Group Inc. hoisted their target price on shares of Illumina (NASDAQ:ILMN) from $73.00 to $74.00 in a report released on Friday, StockRatingsNetwork.com reports. The firm currently has a “neutral” rating on the stock. Goldman Sachs Group Inc.’s price objective suggests a potential downside of 8.65% from the stock’s previous close.
A number of other firms have also recently commented on ILMN. Analysts at Wells Fargo & Co. initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Monday, September 9th. They set an “outperform” rating on the stock. Separately, analysts at Bank of America Corp. set a $90.00 price target on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 22nd. They now have a “buy” rating on the stock. Finally, analysts at Janney Montgomery Scott initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have given a buy rating to the company’s stock. Illumina currently has an average rating of “Hold” and a consensus price target of $74.58.
In other Illumina news, Director David Walt sold 5,000 shares of the company’s stock on the open market in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $83.11, for a total transaction of $415,550.00. Following the transaction, the director now directly owns 926,488 shares in the company, valued at approximately $77,000,418. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Illumina (NASDAQ:ILMN) traded down 1.48% during mid-day trading on Friday, hitting $81.01. 586,320 shares of the company’s stock traded hands. Illumina has a 1-year low of $44.78 and a 1-year high of $85.81. The stock has a 50-day moving average of $79.9 and a 200-day moving average of $70.17. The company has a market cap of $10.136 billion and a price-to-earnings ratio of 96.74.
Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, July 23rd. The company reported $0.43 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter last year, the company posted $0.40 earnings per share. Illumina’s revenue was up 23.3% compared to the same quarter last year. On average, analysts predict that Illumina will post $1.72 earnings per share for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.